Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LevoTako Trial
2024-515060-32-00Phase 3Completed
- Sponsor
- Medical University of Gdańsk
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Takotsubo cardiomyopathy (TCM) comparing Levosimendan with Placebo (2 arms). Primary endpoint: In-hospital LVEF recovery. Started Dec 2024; status: completed.
02
Drugs
levosimendan
03
Conditions
Takotsubo cardiomyopathy (TCM)
Beyond the preview
Go deeper on 2024-515060-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515060-32-00.